As expected, the expression of EPB41L4A-AS2 was negatively correlated with the expression of MKI67 and MYC both in breast cancer patients and the patients in the pancancer cohort (Fig. 7e-h). The gene discussed is EPB41L4A; the disease is breast carcinoma.